Association of HLA Class II Alleles with Disease Severity and Treatment Response in Iranian Patients with Myasthenia Gravis

被引:1
|
作者
Sinaei, Farnaz [1 ]
Fatehi, Farzad [1 ]
Gharan, Shahram Oveis [1 ,2 ]
Ehsan, Soroush [1 ]
Kamali, Koorosh [3 ]
Amirzargar, Aliakbar [4 ,5 ]
Mahmoudi, Mahdi [6 ]
Vaghefifar, Alaleh [1 ]
Nafissi, Shahriar [1 ]
机构
[1] Univ Tehran Med Sci, Shariati Hosp, Dept Neurol, Tehran, Iran
[2] Rush Univ, Med Ctr, Rush Alzheimer Dis Ctr, Chicago, IL 60612 USA
[3] Zanjan Univ Med Sci, Sch Publ Hlth, Dept Publ Hlth, Zanjan, Iran
[4] Univ Tehran Med Sci, Mol Immunol Res Ctr, Sch Med, Tehran, Iran
[5] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[6] Univ Tehran Med Sci, Shariati Hosp, Rheumatol Res Ctr RRC, Tehran, Iran
关键词
Myasthenia gravis; treatment; severity; HLA class II;
D O I
10.3233/JND-210700
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myasthenia gravis is an autoimmune neuromuscular disease with a multifactorial etiology. A major part of the genetic susceptibility belongs to theHLAencoding genes. In this study, we investigated the role ofHLAclass II polymorphism in disease severity, and treatment response. In our 146 patients, 15 DRB1, 7DQA1, and 9DQB1 alleles, and 19 haplotypes were found. Adjusted p-values did not show any significant associations between these loci, disease severity and treatment outcome. Further studies in different populations with a larger number of patients are needed to determine the exact contribution of HLA class II alleles to MG prognosis.
引用
收藏
页码:827 / 829
页数:3
相关论文
共 50 条
  • [41] Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients
    Sebastiani, GD
    Bellisai, F
    Caudai, C
    Rottoli, P
    Valensin, PE
    Pippi, L
    Morozzi, G
    Porciello, G
    Donvito, A
    Bilenchi, R
    Giannini, F
    Galeazzi, M
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2005, 19 (1-2): : 17 - 22
  • [42] Association study of HLA class I and class II alleles with childhood acute lymphoblastic leukemia in Indian patients
    Solanki, Hina
    Tiwari, Aseem Kumar
    Raina, Vimarsh
    Sharma, Girish
    GENE REPORTS, 2021, 23
  • [43] Distribution of HLA class II alleles in patients with rheumatoid arthritis
    Hristova-Dimceva, A.
    Petkovska, V.
    Papes, J.
    Dimitrovski, K.
    Kolevski, P.
    TISSUE ANTIGENS, 2006, 67 (06): : 549 - 549
  • [44] HLA class II alleles and multiple sclerosis in Tunisian patients
    Messadi, Amira
    Najiba, Fekih-Mrissa
    Ouerhani, Slah
    Zaweli, Jemel
    Louatti, Ines
    Layouni, Sami
    Nciri, Brahim
    Bouaicha, Ghaya
    Kouki, Wafa
    Yedeas, Mondher
    Raies, Aly
    Mrissa, Ridha
    Gritli, Nasreddine
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2010, 112 (10) : 849 - 852
  • [45] Association of HLA class I and class II alleles with bullous pemphigoid in Chinese Hans
    Fang, Hui
    Shen, Shengxian
    Zheng, Xiaodong
    Dang, Erle
    Zhang, Jieyu
    Shao, Shuai
    Qiao, Pei
    Li, Qiuju
    Wang, Hua
    Li, Caixia
    Sun, Liangdan
    Wang, Gang
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 89 (03) : 258 - 262
  • [46] Role of HLA class II alleles in Korean patients with IDDM
    Lee, HC
    Ikegami, H
    Fugisana, T
    Ogihara, T
    Park, SW
    Chung, YS
    Park, JO
    Lee, EJ
    Lim, SK
    Kim, KR
    Huh, KB
    Kim, YS
    Lee, DS
    Kim, DH
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1996, 31 (1-3) : 9 - 15
  • [47] Human leukocyte antigens (HLA) association with myasthenia gravis (MG) and its myasthenia manifestations in Algerian patients
    Nadji, Bouchtout Mohamed
    Fethi, Mecabih
    Esma, Mihoubi
    Chahrazad, Boukadir
    Elias, Attal
    Smail, Daoudi
    Chafia, Touil-Boukoffa
    Rachida, Raache
    Nabila, Attal
    META GENE, 2021, 29
  • [48] HLA class II alleles in patients with pemphigus vulgaris in the UK
    Saha, M.
    Harman, K.
    Mortimer, N. J.
    Black, M.
    Kondeatis, E.
    Vaughan, R.
    Groves, R. W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S74 - S74
  • [49] HLA class II alleles in Chinese patients with hepatocellular carcinoma
    Donaldson, PT
    Ho, S
    Williams, R
    Johnson, PJ
    LIVER, 2001, 21 (02): : 143 - 148
  • [50] Use of peptide: HLA class II complexes to study specific T cells in myasthenia gravis
    Kishore, U
    Zhang, W
    Corlett, L
    Kelleher, A
    Shiono, H
    Willcox, N
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (02): : 229 - 229